Ultravist
These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection.ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial useInitial U.S. Approval: 1995
df917c3a-59a2-4ed1-8470-8a5394c73325
HUMAN PRESCRIPTION DRUG LABEL
May 21, 2023
Bayer HealthCare Pharmaceuticals Inc.
DUNS: 005436809
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
iopromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
iopromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
iopromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
iopromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
iopromide
Product Details
FDA regulatory identification and product classification information